Monoclonal antibody therapies in leukemias

This publication has 27 references indexed in Scilit:

• Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy
  Blood, 2002
• Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia
  New England Journal of Medicine, 2001
• Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation
  Cancer, 2001
• Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
  Journal of Clinical Oncology, 2001
• Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
  Blood, 2001
• Immunotoxins in cancer therapy
  Current Opinion in Immunology, 1999
• Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
  Journal of Clinical Oncology, 1990
• Calicheamicin γ ₁ ^I : an Antitumor Antibiotic That Cleaves Double-Stranded DNA Site Specifically
  Science, 1988
• Expression of normal myeloid-associated antigens by acute leukemia cells
  Blood, 1986
• A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells
  Leukemia Research, 1984